Role of Hypothalamic-pituitary-adrenal-axis in Affective Disorders: Anti-depressant and Anxiolytic Activity of Partial 5-HT1A Agonist in Adrenalectomised Rats

por Gupta, Deepali, Radhakrishnan, Mahesh, Bhatt, Shvetank, Kurhe, Yeshwant
Publicado em 2013

Diabetes-associated depression: The serotonergic system as a novel multifunctional target

por Prabhakar, Visakh, Gupta, Deepali, Kanade, Prateek, Radhakrishnan, Mahesh
Publicado no Indian J Pharmacol (2015)

Pharmacological evaluation of novel 5-HT(3) receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery

por Gupta, Deepali, Radhakrishnan, Mahesh, Thangaraj, Devadoss, Kurhe, Yeshwant
Publicado no J Pharm Bioallied Sci (2015)

Anti-anxiety effect of a novel 5-HT(3) receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in mice

por Kurhe, Yeshwant Vijay, Radhakrishnan, Mahesh, Thangaraj, Devadoss, Gupta, Deepali
Publicado em 2014

Neuropharmacological evaluation of a novel 5-HT(3) receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameter...

por Bhatt, Shvetank, Radhakrishnan, Mahesh, Jindal, Ankur, Devadoss, Thangaraj, Dhar, Arghya Kusum
Publicado em 2014

Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression

por Gupta, Deepali, Radhakrishnan, Mahesh, Kurhe, Yeshwant, Thangaraj, Devadoss, Prabhakar, Visakh, Kanade, Prateek
Publicado no Acta Pharmacol Sin (2014)